Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?

Published:2016-04-20 Issue:43 Volume:37 Page:3260-3266
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Willeit Peter,Skroblin Philipp,Kiechl Stefan,Fernández-Hernando Carlos,Mayr Manuel

Funder

Austrian Science Fund

British Heart Foundation

Fondation Leducq Transatlantic Network of Excellence in Cardiovascular Research

Diabetes UK

Austrian Research Promotion Agency FFG

NIHR Biomedical Research Center

King's College Hospital

National Institutes of Health

American Heart Association

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/37/43/3260/8326009/ehw146.pdf

Reference98 articles.

1. MicroRNAs: Target Recognition and Regulatory Functions

2. Regulation of miRNA strand selection: follow the leader?

3. Pervasive roles of microRNAs in cardiovascular biology

4. Novel methodologies for biomarker discovery in atherosclerosis

5. MicroRNA regulatory networks in human adipose tissue and obesity

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of microRNA-126 in Adipose-Derived Mesenchymal Stem Cells Alleviate the Alcoholic Liver Injury;2024-08-05

2. Circulating afamin positively correlated with the miR-122 expression and type 2 diabetes mellitus-related phenotype according to the duration of diabetes;Heliyon;2024-04

3. Breaking barriers: Overcoming low abundance of miR-122 with E-DDM for precise detection in HCC patients;Sensors and Actuators B: Chemical;2024-04

4. Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?;Pharmacological Research;2024-03

5. CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology;Journal of Translational Medicine;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3